SUMMARY Evidence of acute pancreatitis was sought in 35 patients with fulminant hepatic failure. Total amylase was raised in 22 patients and isoenzyme separation showed a distinct P3 isoenzyme
Acute pancreatitis has been a recognised complication of acute viral hepatitis for more than 40 years' and more recently has been reported to occur in patients with fulminant hepatic failure.' These reports have been based largely on retrospective analyses of post mortem findings. In a combined prospective and retrospective study, Parbhoo et all found that total serum -amylase was increased in 33% of patients with fulminant hepatic failure (FHF) as defined by Trey Blood samples were taken within 24 hours of admission and sera stored at -20°C for subsequent analysis. Total amylase activity was determined by hydrolysis of a dyed starch matrix (Phadebas, Pharmacia Diagnostics). Pancreatic lipase was determined using a turbidimetric assay'2 (Boehringer Mannheim). Amylase isoenzymes were separated essentially as described by Legaz 
Results
Total amylase activity was normal in all 22 controls (normal range 70-300 U/l) and separation of amylase isoenzymes showed the P2, S1S2 pattern in 13 and a P2, S1 pattern in the remaining nine subjects. In none of the 22 subjects was a P3 isoenzyme detected. Pancreatic lipase was not assayed in this group as we have previously found close agreement in normal subjects with the manufacturers' quoted normal range (50-200 U/l) in healthy volunteers. Electrophoresis of the pooled control yielded five peaks with a P2P3, S1S2S3 pattern.
Total amylase activity was greater than 300 U/l in 22 of the 35 patients and in 11 values exceeded 1000 U/l. In 34 of the 35 patients pancreatic lipase activity exceeded 200 U/l and in 12 of these the lipase activity was greater than 1000 U/l. the 29 patients with total amylase exceeding 200 U/l. A distinct P3 isoenzyme was shown in 14 patients and in 12 pancreatic lipase was greater than 1000 U/l (mean 2300 U/l (385) (SE)). The P3 isoenzyme was not detectable in seven of the patients and in eight was only faintly present -for statistical purposes these two groups will be considered together (Figure) . The difference in the mean pancreatic lipase between those patients with a distinct P3 isoenzyme and those without was significant (p<0-005), whereas the difference between the mean amylase values was not (p>0-05, Table 1 ). Four of the seven patients with no detectable P3 isoenzyme had a total amylase greater than 1000 U/I and this increase was due predominantly to a rise in the salivary fraction.
The effect of renal impairment on total amylase and pancreatic lipase is shown in 
Discussion
A number of studies have now shown that the P3 isoenzyme of amylase is a more specific marker of acute pancreatitis than serum amylase alone.' 3l Using this test in addition to an assay for pancreatic lipase we have found biochemical evidence of acute pancreatitis in 34% of patients with FHF, a frequency close to that found in necropsy studies. 4 Up to now the diagnosis has usually been based on the finding of a grossly raised amylase activity (>1000 U/l). The present results, however, suggest that a significant number of patients (six of 23) with an amylase of less than 1000 U/I have biochemical evidence of pancreatitis. Furthermore, one third of patients with a grossly raised total amylase had salivary hyperamylasaemia with no detectable P3 isoenzyme and P-lipase less than 1000 U/I. Although termed 'salivary' this isoenzyme of amylase may be derived from many tissues other than salivary gland, such as lung and ovary"'7 and it may also be raised after intracranial haemorrhage.'3 Its origin in the patients with FHF is unclear although it may be related to respiratory disease.
While identification of the P3 isoenzyme greatly improves the diagnostic accuracy, this technique is time consuming. The pancreatic lipase assay, however, is rapid, cheap, and easy to do. We suggest that a higher cut off (1000 U/l) be used before making the diagnosis of pancreatitis in FHF, as only such values were associated with the presence of the P3 isoenzyme. It is of interest that the mortality in patients with evidence of biochemical pancreatitis was not significantly different from those patients without this complication. It would seem therefore, that in the majority of cases the pancreatitis was not severe, although a small increase in mortality could have been obscured by the overall high mortality of the group (57%). It was noted that the serum bicarbonate was lower in those patients with evidence of pancreatitis and that this difference was not caused by renal failure. This may be because of a higher incidence of lactic acidosis in this group, which is a recognised complication of FHF,`3 although serum lactate was not measured in this study. Although renal failure may result in hyperamylasaemia there is no direct correlation between total serum amylase and the severity of renal failure. In this study we found no significant difference in total serum amylase in those with and those without renal impairment.
With regard to the pathogenesis of pancreatitis in FHF the earliest reports considered this complication was the result of direct cytopathic effect of the virus concerned.2 3While such effects may be important in cases of viral hepatitis, it is apparent that pancreatitis may also complicate FHF caused by paracetamol overdose and halothane hepatitis. While the precise mechanism involved remains uncertain, the demonstration of increased lysosomal activity in the sera of patients with FHF by Gove et al" may well be of relevance. Circulating lysosomal proteases are known to damage other organs including the lungs"' and kidney22 and presumably could also damage the pancreas. Pancreatic damage could also be mediated by the formation of free radicals which are present in increased concentrations in FHF. In this context it is of interest that experimentally induced pancreatitis may be ameliorated by infusion of the free radical scavengers superoxide dismutase and catalase. 23 Attempts to limit free radical formation and lysosomal enzyme release may reduce the incidence of pancreatitis and would be worth evaluating in patients with FHF. 
